semaj83/ctmatch_classification huggingface dataset:
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 14.0-18.0,  Primary Dysmenorrhea Female aged 14-18 years 2. Self-reported menstrual cycle averaging 22-35 days 3. Access to a smartphone or email 4. Right handed 5. Body Mass Index (BMI) of 35 or less 6. Able to read and understand English 7. Ability and willingness to provide written informed assent/consent 8. Availability of a parent to provide written parental permission (for participants under age 18)  Use of oral contraceptives or any exogenous hormones in the previous 3 months prior to participation 2. Presence of factors indicative of secondary dysmenorrhea (e.g., self-reported presence of persistent pelvic pain throughout the month) 3. Diagnosis of chronic pain condition (e.g., Irritable bowel syndrome (IBS), functional abdominal pain, interstitial cystitis/painful bladder syndrome) 4. Current self-reported severe depression, bipolar disorder, panic disorder, or ADHD, or current treatment for these conditions 5. Diagnosis of an eating disorder within the last 6 months 6. Current or past diagnosis of any psychotic disorder 7. Currently pregnant 8. Self-reported weekly use of alcohol, cannabis, and/or other illegal substances 9. Use of stimulants (including methamphetamine and/or medications for the treatment of ADHD) or opioids in the previous 3 months. Participants who use other analgesics will be included but will be requested to not take these analgesics within the previous 24 hours of the laboratory session 10. History of pelvic inflammatory disease or sexually transmitted disease 11. Acute illness or injury that would potentially impact pain task performance (e.g., fever, flu symptoms) or that affect sensitivity of the extremities (e.g., Reynaud's disease). Potential participants who are being treated for cardiovascular disease(s) will be included pending discussion with the participant's primary physician 12. Developmental delay, diagnosis of autism, or significant cognitive impairment that may preclude understanding of study procedures 13. Presence of any ferromagnetic appliance or implants (braces, retainers, spacers, wires, screws, etc.) in the mouth or any other body part, which is a contraindication for the magnetic resonance imaging (MRI) scanner 14. Significant fear of enclosed places (claustrophobia)
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 15.0-90.0,  Graves Disease Untreated Graves' hyperthyroidism. (elevated serum free T4 and/or free T3 level, suppressed serum TSH level, positive anti-TSH receoptor antibody and high thyroidal radioactive iodine uptake -  dropped out patients within 180 days -
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-60.0,  Hashimoto Disease Psoriasis Hashimoto's Thyroiditis Clinical findings Presence of thyroid autoantibodies (anti-TPO) in laboratory tests Gray-scale Ultrasound findings. Psoriasis Presence of psoriatic lesions Psoriasis Area and Severity Index score (PASI). Healthy group: Non-obese (BMI<30) non-athletes non-pregnant or lactating women not been diagnosed with a chronic or acute disease not receiving antidepressants, drugs and supplements  malignant or congenital goiter thyroidectomy
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 25.0-42.0,  Infertility Indication to IVF treatment Normal BMI (18.5-24.9 kg/m2) AMH level < 1.1 ng/ml and/or AFC < 5 follicles and/or < 3 oo-cytes retrieved in previous cycle Regular menstrual cycles Signed informed consent  Freeze all cycles for abnormal bleeding PCOS History of untreated autoimmune Endocrine or metabolic disorders Ovarian cystectomy or oophorectomy FSH ≥ 20 lU/L
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 14.0-999.0,  Adolescent Pregnancy All subjects must be able to read and write Spanish RCT will be limited to pregnant adolescents who are between the ages of 14-19 years and 12-34 weeks gestational age. Other caregivers (age 14 years or older) will be eligible if they are planning to be involved in infant care Only pregnant adolescents receiving outpatient prenatal care at INMP or San Bartolomé will be approached as potential participants Only pregnant adolescents who have been cleared by their attending doctor/nurse to engage in the approach/recruitment and interview procedure will be approached as potential participants All infants born to adolescents enrolled during pregnancy will be eligible to be enrolled after birth  Anyone unable to read and write Spanish Any pregnant adolescent known to have a severe fetal anomaly will not be approached Infants who are advised not to participate by their attending doctor or pediatrician Children or adolescents who are wards of the state will not be enrolled
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 0.0-3.5,  Congenital Hypothyroidism Children with congenital hypothyroidism Eutopic thyroid gland or thyroid hemiagenesis Born between 1996 and 2017 Treated at the Nancy Regional and University Hospital Follow-up of at least 3,5 years  Polymalformative syndrome Thyroid dysgenesis except for thyroid hemiagenesis
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Rotator Cuff Repair Ankle Arthroplasty or Arthrodesis Hallux Valgus (Bunion) Resection 18 years of age or older. 2. Undergoing one of the following surgical procedures: rotator cuff repair, ankle arthrodesis or arthroplasty, hallux valgus correction. 3. With a planned single-injection peripheral nerve block for postoperative analgesia  Chronic analgesic use including opioids (daily use within the 2 weeks prior to surgery and duration of use > 4 weeks). 2. Neuro-muscular deficit of the target nerve(s). 3. Compromised immune system based on medical history (e.g., immunosuppressive therapies such as chemotherapy, radiation, sepsis, infection), or other conditions that places the subject at increased risk. 4. Implanted spinal cord stimulator, cardiac pacemaker/defibrillator, deep brain stimulator, or other implantable neurostimulator whose stimulus current pathway may overlap. 5. History of bleeding disorder. 6. Antiplatelet or anticoagulation therapies other than aspirin due to the risk of bleeding with a 20-gauge insertion needle. 7. Allergy to skin-contact materials (occlusive dressings, bandages, tape etc.) 8. Incarceration. 9. Pregnancy. 10. Chronic pain of greater than 3 months of any severity in an anatomic location other than the surgical extremity. 11. Anxiety disorder. 12. History of substance abuse. 13. Inability to contact the investigators during the treatment period, and vice versa (e.g., lack of telephone access)
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Pre-Eclampsia Gestational Diabetes women within 12 months of a live birth After a pregnancy where women were diagnosed with preeclampsia and/or GDM (diagnosed) within 12 months post-partum Between 18 and 50 years old  We will women with serious complications of preeclampsia and or/GDM as perinatal mortality or multi-organ failure
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 10.0-17.0,  Hyperandrogenism Polycystic Ovary Syndrome Puberty Mid to late pubertal adolescent girls as signified by either (a) post-menarcheal status (Tanner breast stages 2-5) or (b) Tanner breast stage of 4 or 5 (whether pre-menarcheal or post-menarcheal) ages 10-17 years Hyperandrogenism, defined as a serum (calculated) free testosterone concentration greater than the Tanner stage-specific reference range and/or clinical hirsutism General good health (excepting obesity, hyperandrogenism, PCOS, and adequately-treated hypothyroidism) Willing to strictly avoid pregnancy with use of reliable non-hormonal methods during the study period  Inability/incapacity to provide informed consent Males will be excluded (hyperandrogenism is unique to females) Age < 10 or > 17 years (this study is designed to elucidate mechanisms underlying emerging PCOS in mid to late pubertal adolescent girls Post-menarcheal by > 4 years Obesity resulting from a well-defined endocrinopathy, or genetic syndrome To ensure that blood withdrawal is within safe limits, weight < 21.5 kg is an criterion Since underweight can alter pulsatile LH secretion, BMI-for-age percentile < 5 is an criterion Positive pregnancy test or current lactation. Subjects with a positive pregnancy test will be informed of the result by the screening physician. Under Virginia law, parental notification is not required for minors. However, the screening physician will encourage the subject to tell her parent(s). We will counsel the adolescent about the importance of appropriate prenatal care/counseling. We will offer appropriate follow-up at the Teen Health Clinic at UVA and/or encourage the adolescent to secure prompt care via their primary care physician's office Evidence for non-physiologic or non-PCOS causes of hyperandrogenism and/or anovulation
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Congenital Hypothyroidism Patients having a documented history of CH diagnosed by Egyptian neonatal screening program Patients receiving L-thyroxine (L-T4) since the diagnosis is established  Patients who are non-compliant on L-thyroxine (L-T4) and failed to follow up at the clinic on regular basis Patients who were missed from diagnosis by neonatal screening Patients with associated hormonal disorders affecting same parameters concerned in the study
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cancer Smoking Tobacco Use Nicotine Dependence Clinician participants must meet the following for enrollment: 1. Currently in practice at an Implementation Lab site (UPHS) 2. Prescribing authority in Pennsylvania (i.e., physician, nurse practitioner, physician assistant) 3. Cared for at least 1 tobacco-using patient in 30 days prior to recruitment 4. English-speaking (messages will be in English) Patient participants must be diagnosed with cancer and report current tobacco smoking (as assessed by an MA during an Index Visit)
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-39.0,  BMI/Body Composition Are between the ages of 18 (or 17 for military personnel) and 39 (i.e., consistent with the age range of 95% of Active Duty enlisted and 75% of Active Duty officers) Have a Body Mass Index (BMI) in the range of 18.5 to <25 kg/m2 and have a percent body fat by circumference measurements that meets the Army's max allowable body fat standards for individuals classified as "without obesity"; or have a BMI ≥ 30 kg/m2 and have a percent body fat by circumference measurements that exceeds the Army's max allowable body fat standards for individuals classified as "with obesity" (40) Have been weight stable (+/ lbs.) for the past two months (not including temporary body weight fluctuations due to menstrual cycle) and agree not to attempt to lose or gain weight for the duration of the study Participate in 120-300 mins of aerobic exercise over the course of at least 3 days per week as indicated by self-report data and confirmed during the study via actigraphy (i.e., consistent with the self-reported exercise habits of a majority of active duty military personnel) (1, 41) Are willing to participate in all study procedures and comply with all study instruction Females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or able to provide documentation of oral/hormonal contraceptive use which contains low-dose estrogen/progesterone to maintain continuous levels throughout the 28-day cycle (i.e., no placebos) Pass a general medical clearance  have a tattoo on both forearms that obscures the forearms and doesn't allow space for the suction blister induction experienced more than a ~5 lbs. weight gain or loss in the last month than is not transient (e.g., menstrual) participate in more than 300 minutes of aerobic exercise per week as indicated by self-report data and confirmed during the study via actigraphy (i.e., consistent with self-reported exercise habits of ~20% of active duty military personnel) (1, 41) are habitually taking nonsteroidal anti-inflammatory drugs (e.g., Advil), aspirin, lipid-lowering drugs, corticosteroids or immunosuppressants (e.g. Humira) are immune-compromised (e.g., chemotherapy or radiation treatment) are suffering from an autoimmune disease (e.g., lupus) recovering from a surgery within the past 6 months Current doctor-diagnosed and/or treated diabetes, hypertension or dyslipidemia are suffering from sleep apnea smoke, dip, chew or vape tobacco or nicotine-containing products
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 0.5-0.654,  Feeding Intolerance in Preterm Intestinal Permeability in Preterm preterm infants delivered at gestational age 26 to 34 weeks admitted to NICU OF mansoura university children hospital Diagnosed as feeding intolerance defined as gastric volume residual of more than 50% of the previous feeding volume, gastric regurgitation, abdominal distention and or emesis Receive premature cow's protein based formula enteral feeding  Major congenital malformations Anatomical gastrointestinal anomalies Birth asphyxia Presence of NEC Neonate receiving Expressed breast milk Infant with history of cow's milk allergy -
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 30.0-45.0,  Low Back Pain Being a member of the original Western Zealand cohort Ability to understand and write in Danish Having access to the Danish digital mail system "e-Boks". (Access to e-Boks is mandatory in Denmark unless you have special needs)  We have no formal
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Hashimoto Disease Obesity Diagnosed with Hashimoto's disease BMI over 30 kg/m2 Taking the L-thyroxine, 200 mcg of 1-selenomethionine/day, and 30 mg of zinc gluconate/day throughout the study period  ---
Patient description: A 16-year-old girl came to the clinic complaining of weight gain and abnormal menstrual cycles. Her BMI was 24, but she has gained 5 kg in the past few weeks. She gets tired more frequently and does not have energy to go dancing with her friends. Her lab results were remarkable for high TSH levels (15 mU/L) and low free T4 levels (0.18 ng/dl). Her anti-TPO levels were extremely high (136 IU/ml). She was diagnosed with Hashimoto disease. She does not smoke and she is not sexually active.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Hashimoto Thyroiditis Autoimmune Thyroiditis Thyroiditis Thyroid Diseases Autoimmune Diseases Cases between the ages of 18-65 who applied to the Kosuyolu Istanbul Medipol Hospital Endocrinology and Metabolic Diseases Clinic between 2020-2021 and diagnosed as "Hashimoto Thyroiditis" by a specialist physician will be included in the study  Acute infection Use of immunosuppressants, immunostimulants and drugs that interfere with the production, transport, and metabolism of thyroid hormones Thyroid nodules Tracheal stenosis Serious illness History of exposure to ionizing radiation and/or neoplasia in the cervical region Malignancy and a history of thyroid surgery Hypothyrodism caused by postpartum thyroiditis Pregnancy and breastfeeding period Identification and diagnosis of the cases with neurological and psychiatric disorders